Iyengar, M., O’Hayer, P., Cole, A., Sebastian, T., Yang, K., Coffman, L., & Buckanovich, R. J. (2018). CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer. Oncotarget.
Styl cytowania ChicagoIyengar, Mangala, Patrick O’Hayer, Alex Cole, Tara Sebastian, Kun Yang, Lan Coffman, i Ronald J. Buckanovich. "CDK4/6 Inhibition As Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer." Oncotarget 2018.
Styl cytowania MLAIyengar, Mangala, et al. "CDK4/6 Inhibition As Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer." Oncotarget 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..